Statins are being overprescribed, study suggests
The risks of statins for primary prevention are greater than the benefits for many patients Related items fromOnMedica Withdrawn valsartan meds not linked to short-term cancer risk Direct oral anticoagulants as safe as warfarin after VTE Too few women take part in many CVD clinical trials Use of DPP-4 inhibitors associated with increased risk of IBD Metformin doesn ’t help HbA1c in teens with type 1 diabetes (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 4, 2018 Category: UK Health Source Type: news

Barriers to using stroke-preventing anticoagulants in Canada hinder appropriate management of patients with atrial fibrillation
(Elsevier) International guidelines recommend direct oral anticoagulants (DOACs) over warfarin to prevent stroke for most patients with atrial fibrillation (AF). However, a substantial portion of patients in Canada, who would benefit from anticoagulation, do not receive it adequately or at all. Experts review the evidence for the use of DOACs in the Canadian Journal of Cardiology, discuss reasons for the large gap between guidelines and clinical practice, including policy and funding barriers, and propose strategies for the future. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 5, 2018 Category: International Medicine & Public Health Source Type: news

FDA issues Class I recall for Roche Diagnostics ’ warfarin test strips
The FDA today issued a Class I recall for certain lots of Roche Diagnostics‘ warfarin test strips used with the CoaguCheck test meter devices. Roche voluntarily recalled the strips in September, warning that for patients and doctors who use at-home devices to monitor levels of the blood thinner, the devices may yield inaccurate results. The FDA said today that the devices should not be used to adjust drug dosages. Get the full story at our sister site, Drug Delivery Business News. The post FDA issues Class I recall for Roche Diagnostics’ warfarin test strips appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 2, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diagnostics Food & Drug Administration (FDA) Pharmaceuticals Recalls Regulatory/Compliance Vascular Wall Street Beat Roche Diagnostics Source Type: news

FDA recalls devices over inaccurate warfarin test results
The Food and Drug Administration announced a recall of test strips that monitor levels of the blood thinner wafarin may give inaccurate results. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 2, 2018 Category: Consumer Health News Source Type: news

FDA recalls test strips over inaccurate warfarin test results
The Food and Drug Administration has announced a recall of test strips that monitor levels of the blood thinner warfarin because they may give inaccurate results. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 2, 2018 Category: Consumer Health News Source Type: news

Warfarin INR Test Strips Recalled
(MedPage Today) -- Class I recall for over 1.1 million packages of CoaguChek XS PT strips (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 2, 2018 Category: American Health Source Type: news

FDA: Class I Recall of Roche Warfarin INR Test Strips FDA: Class I Recall of Roche Warfarin INR Test Strips
The problematic strips, used with CoaguChek anticoagulation meters, could lead to warfarin doses that are too low. Roche says it is issuing properly functioning replacements.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 2, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

FDA warns patients and doctors about risk of inaccurate results from home-use device to monitor blood thinner warfarin
Roche Diagnostics issued voluntary recall of certain test strips used with CoaguChek meter devices; patients affected by the recall should seek alternative methods for testing. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 1, 2018 Category: American Health Source Type: news

Dabigatran, Rivaroxaban, Warfarin in Oldest Adults With AF Dabigatran, Rivaroxaban, Warfarin in Oldest Adults With AF
This study compared the effectiveness and safety of reduced-dose dabigatran, reduced-dose rivaroxaban, and warfarin in individuals aged 85 and older with atrial fibrillation.Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 1, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Impact of a 4F-PCC Protocol in Warfarin-Associated ICH Impact of a 4F-PCC Protocol in Warfarin-Associated ICH
A pharmacist-driven 4F-PCC protocol for warfarin-associated intracranial hemorrhage may help reduce time to administration.Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2018 Category: Consumer Health News Tags: Emergency Medicine Journal Article Source Type: news

NOACs for Mechanical Heart Valves: Is the Door Still Open? NOACs for Mechanical Heart Valves: Is the Door Still Open?
Currently, NOACs are contraindicated in patients with mechanical heart valves based on the results of a single study comparing dabigatran and warfarin. Does this need to be re-evaluated?Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 22, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Air pollution link to heightened mouth cancer risk
High levels of fine particulate matter seem key Related items fromOnMedica Lower cancer risk in people with higher vitamin D levels Global cancer burden set to soar Cancer survival rates not improved much in a decade Warfarin is not the answer for thromboses in cancer patients The NHS must adapt now to care for older cancer patients (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 10, 2018 Category: UK Health Source Type: news

Meta-Analysis: Oral Anticoagulant Choice Matters in Afib Cardioversion
(MedPage Today) -- DOACs may be better than warfarin at preventing thromboembolic events (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 8, 2018 Category: Cardiology Source Type: news

Net Benefit of Anticoagulants for A - Fib Varies With Stroke Rate
Benefit of warfarin anticoagulation varies with varying published stroke rates (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 25, 2018 Category: Cancer & Oncology Tags: Cardiology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Anticoagulation on Warfarin Weakens After 6 Months
(MedPage Today) -- But patients hitting TTR target still had fewer events (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 12, 2018 Category: Cardiology Source Type: news